Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Human Molecular Genetics|September 23, 2010
A centronuclear myopathy-dynamin 2 mutation impairs skeletal muscle structure and function in miceAnne-Cécile Durieux, Alban Vignaud, Bernard Prudhon, et al.
Molecular Therapy. Methods & Clinical Development|May 17, 2018
Influence of Pre-existing Anti-capsid Neutralizing and Binding Antibodies on AAV Vector TransductionZachary Fitzpatrick, Christian Leborgne, Elena Barbon, et al.
Plos One|August 23, 2011
Increased muscle stress-sensitivity induced by selenoprotein N inactivation in mouse: a mammalian model for SEPN1-related myopathyMathieu Rederstorff, Perrine Castets, Sandrine Arbogast, et al.
Pharmacology Research & Perspectives|October 11, 2021
Recombinant botulinum neurotoxin serotype A1 in vivo characterizationCindy Périer, Vincent Martin, Sylvie Cornet, et al.
Molecular Therapy. Methods & Clinical Development|October 11, 2016
A translationally optimized AAV-UGT1A1 vector drives safe and long-lasting correction of Crigler-Najjar syndromeGiuseppe Ronzitti, Giulia Bortolussi, Remco van Dijk, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|June 27, 2014
Myostatin is a key mediator between energy metabolism and endurance capacity of skeletal muscleEtienne Mouisel, Karima Relizani, Laurence Mille-Hamard, et al.
Plos One|April 19, 2012
Impaired adaptive response to mechanical overloading in dystrophic skeletal musclePierre Joanne, Christophe Hourdé, Julien Ochala, et al.
Pageof 4